Latest ADHD Stories
TAU researchers develop diagnostic tool for the most commonly misdiagnosed disorder.
Parent company C8 Sciences’ innovative ACTIVATE™ program at the center of helping ADHD in the classroom while delivering real-time cognitive data reports and greatly improving academic outcomes.
Attention Point® is pleased to announce the “Weiss ADHD Comorbid Screen” (WACS) and the “Teacher Report of School Function”, both developed by Dr.
Two recent studies reveal that child abuse is much more common in ADHD and dyslexia. In Dr.
LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events.
Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S.
LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc.
Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people.
BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product
- An imitative word; an onomatopoetic word.